Best Buy clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Best Buy
BBY · a US exchange · USD · Market cap $19.4B · 82,000 employees
Best Buy Co., Inc.
Not yet scoredPrice as of 16 Oct 2026Daily close, not a live quoteLast reviewed 11 days ago
Screened 2026-10-16 · the tape above runs as of 18:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price92.63 USD at the 16 Oct 2026 close
- Our ratingFair value, current read markup
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.50)
- Last reviewed16 Oct 2026 (11 days ago)
A summary of the dated readings below, not a live quote and not advice.
What this means: price 92.63 against the desk's fair-value range, base estimate 100.00, over the last year.
- Trend Markup
- Insiders insiders sold, $10,695,364, latest filing 2026-09-23
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.50, read 2026-10-25
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Best Buy holds its Markup at $92.63. Consolidating, no directional conviction, held for 18 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 18 days |
| Price at the screen | $92.63 |
| Valuation | 15.41 trailing · 12.83 forward price to earnings |
| Values screen | Not scored · score 84.6 |
| Beta | 1.28 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 28.17% | Below 33% | Interest-bearing debt is just 28.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 18.96% | Below 49% | Money owed to the company is 19.0% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Best Buy clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Best Buy clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 28%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads FAIR VALUE: it trades at roughly a 8% discount to our $100.00 fair value, weak competitive moat, 3.60% revenue growth.
Fair value range in USD, drawn from the 2026-10-16 screen. The gold marker is the market price at the same screen. A 8.0% margin of safety to the base estimate.
Third-party analyst targets: 20 covering, consensus Hold. The average target sits −7% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-16 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsTech shelves still draw weekend crowds
Walk into any Best Buy on a Saturday and families still linger over laptops and phones in person. That hands-on habit keeps the tills ringing even as pure online rivals pile in.
The shares sit 5 percent below our fair value at 12.1 times forward earnings. A 39 percent return on equity and a clean ethical screen stand out against 2 percent revenue growth and a 3 percent profit margin.
Yet the moat is weak and the business sits squarely in a cyclical corner. The low multiple may simply mark peak earnings rather than a bargain, and twenty analysts cluster around a hold with an $80 target. Analysis, not advice.
| Forward P/E | 12.8xexpensive even after accounting for its growth |
| Trailing P/E | 15.4xreasonably valued |
| EPS, trailing | 6.01 |
| EPS, forward | 7.22 |
| Revenue growth | +3.6%slow but positive growth |
| Profit margin | 3.0%barely profitable |
| Return on equity | 43.1%an exceptional return on shareholder capital |
| FCF yield | 7.22% |
| Dividend yield | 6.77% |
| Debt to equity | 1.30a meaningful debt load worth watching |
| Current ratio | 1.12adequate liquidity, worth monitoring |
| Beta | 1.28moves a little more than the market |
| Short interest, float | 0.08% |
| 52-week range | 55.10 - 96.53 |
| Moat | WEAK |
| Market cap | $19.4B |
| Employees | 82,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBBY trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $88.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.5% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $88.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $87.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.5% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $87.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $83. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $83. It reported earnings in this window, a natural checkpoint for the thesis.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 9.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $83. It reported earnings in this window, a natural checkpoint for the thesis.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (20 analysts) rates it hold, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Best Buy (BBY) In Focus Following IGN Deal As Valuation Debate Heats Up Yahoo Finance · 4d ago
- Alpine Income Property Trust, Inc. Q3 2026 Earnings Call Summary Yahoo Finance · 4d ago
- Best Buy Co., Inc. (BBY) Hit a 52 Week High, Can the Run Continue? Yahoo Finance · 4d ago
- Best Buy (BBY) is a Top Dividend Stock Right Now: Should You Buy? Yahoo Finance · 5d ago
- Are Retail-Wholesale Stocks Lagging Best Buy (BBY) This Year? Yahoo Finance · 5d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-23 | Scarlett Kathleen | SEVP, CHRO | S - Sale+OE | 116,062 | $10,695,364 |
| 2026-09-16 | Schulze Richard M | Chairman Emeritus | S - Sale | 300,000 | $27,754,213 |
| 2026-04-15 | SCHULZE RICHARD M | Former | 21,914 | · | |
| 2026-03-23 | BILUNAS MATTHEW M. | Chief Financial Officer | 11,356 | $727,000 | |
| 2026-03-23 | SCARLETT KATHLEEN | Officer | 8,049 | $515,289 | |
| 2026-03-23 | HARTMAN TODD G. | General Counsel | 5,339 | $341,797 | |
| 2026-03-23 | BONFIG JASON J | Officer | 6,336 | $405,624 | |
| 2026-03-23 | WATSON MATHEW | Officer | 3,298 | $211,135 | |
| 2026-03-23 | BARRY CORIE S | Chief Executive Officer | 42,869 | $2,744,431 | |
| 2026-03-20 | BONFIG JASON J | Officer | 23,886 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-05-01 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $57.62 | +32.3% | · | $1,323 | +32.3% |
| 2 months | $62.37 | +22.2% | · | $1,222 | +22.2% |
| 3 months | $61.66 | +23.6% | $0.96 | $1,252 | +25.2% |
| 6 months | $72.88 | +4.6% | $1.91 | $1,072 | +7.2% |
| 1 year | $70.91 | +7.5% | $3.81 | $1,129 | +12.9% |
| 2 years | $79.03 | -3.5% | $7.58 | $1,061 | +6.1% |
| 3 years | $64.95 | +17.4% | $11.28 | $1,348 | +34.8% |
| 5 years | $91.63 | -16.8% | $17.82 | $1,027 | +2.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BBY does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.